{
  "id": 7627653,
  "title": "QT Imaging at IAccess Alpha conference: growth, reimbursement push",
  "url": "https://urgent.news/2026/09/15/qt-imaging-at-iaccess-alpha-conference-growth-reimbursement-push",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T20:34:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/qt-imaging-at-iaccess-alpha-conference-growth-reimbursement-push-93CH-4902585"
  },
  "original_language": "en",
  "account": null,
  "summary": "QT Imaging Holdings, Inc. (QTI) recently presented its growth story at the IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, focusing on its Breast Acoustic CT platform. The company reported a significant revenue increase from $4.9 million in 2024 to $18.9 million in 2025, with $14 million in the first half of 2026 and a full-year 2026 guidance of about $39 million. QT Imaging expects a Category III CPT code to take effect on January 1, 2027, which will help standardize billing and support broader payer reimbursement. The company has shifted from a hardware-led model to a platform model, incorporating cloud software and AI tools beginning in 2027. QT Imaging has imaged over 12,000 women in real-world use and is building clinical evidence through studies at Mayo Clinic and Odette Cancer Centre. The company strengthened its balance sheet with a $10 million offering and a loan maturity extension to March 31, 2029. QT Imaging shipped 28 scanners in the first half of 2026, double the prior-year period, and gross margins have remained around 45%, with a current market capitalization of $38 million.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}